MGNXのPER（株価収益率）は？

MACROGENICS INC（MGNX）は現在PER 14.28倍で取引されています。

MGNXのROE（自己資本利益率）は？

MACROGENICS INCのROEは-331.91%です。

MGNXの配当利回りは？

MACROGENICS INCの配当利回りは0.00%です。

MGNXの品質スコア（Quality Score）は？

当社のAIはMGNXの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

MGNXは今が買い時ですか？

当社AIのタイミングスコアは100点中55点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

MGNXはどのセクターに属しますか？

MACROGENICS INCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

MGNX (NASDAQ) 株価分析 | MACROGENICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

MGNX AI Analysis Summary

Our AI summary for MGNX: MACROGENICS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 14.28, ROE of -331.91%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 55/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

MGNX

MACROGENICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 3.69

-0.09 (-2.38%) Day Change

Watchlist Portfolio Compare Chart

14.28

P/E

0.25

D/E

-331.9%

ROE

-32.3%

ROA

0.00%

Div Yield

0.08

PEG

MACROGENICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.69 Price -0.09 (-2.38%) Day Change	NEWS SCORE: N/A

MGNX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.69
PBV / Sector	11.33 / 5.20
Earning Per Share	-1.08

PE / Sector	14.28 / 19.97
PEG or PE/Growth / Sector	0.08 / 1.22 GREAT
Average 1M Daily Value	3.47 M GREAT
Average 1W Daily Value	2.02 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-44.79 / 98.71
NPM Average (%) / Sector	-46.94 / -1,721.76
NPM Change Average (%) / Sector	26.35 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-32.29 / 27.02
ROA Average (%) / Sector	-26.29 / -368.17
ROA Change Average (%) / Sector	168.79 / 5,404.12 GREAT
ROE (%) / Sector	-331.91 / 3.47
ROE Average (%) / Sector	-122.86 / 6.51
ROE Change Average (%) / Sector	264.77 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:10
Symbol	MGNX
Name	MACROGENICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	63.56 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	240.27 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 9704 Medical Center Drive, Rockville, MD, United States, 20850

Phone: 301 251 5172

Website: https://www.macrogenics.com

Employees: 293

Sector: Healthcare >> Biotechnology

Description: MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.